Compared with NSCLC patients with low SNAI1 expression levels, those with high expression levels had a 1.98-fold higher risk of developing brain metastases (95% CI 1.00–3.95; P = 0.051). This evidence concerns the gene SNAI1 and non-small cell lung carcinoma.